Matthew David
2021
In 2021, Matthew David earned a total compensation of $1.4M as Executive Vice President and Chief Financial Officer at CorMedix, a 30% increase compared to previous year.
Compensation breakdown
| Bonus | $75,900 |
|---|---|
| Option Awards | $951,895 |
| Salary | $351,923 |
| Other | $43,584 |
| Total | $1,423,302 |
David received $951.9K in option awards, accounting for 67% of the total pay in 2021.
David also received $75.9K in bonus, $351.9K in salary and $43.6K in other compensation.
Rankings
In 2021, Matthew David's compensation ranked 7,471st out of 12,415 executives tracked by ExecPay. In other words, David earned more than 39.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,471 out of 12,415 | 40th |
Division Manufacturing | 3,286 out of 5,505 | 40th |
Major group Chemicals And Allied Products | 1,454 out of 2,375 | 39th |
Industry group Drugs | 1,295 out of 2,096 | 38th |
Industry Pharmaceutical Preparations | 953 out of 1,546 | 38th |
Source: SEC filing on August 30, 2022.
David's colleagues
We found six more compensation records of executives who worked with Matthew David at CorMedix in 2021.
2021
Khoso Baluch
CorMedix
Chief Executive Officer
2021
Thomas Nusbickel
CorMedix
Former Chief Commercial Officer
2021
Phoebe Mounts
CorMedix
General Counsel
2021
John Armstrong
CorMedix
Former Executive Vice President for Technical Operations
2021
Elizabeth Masson-Hurlburt
CorMedix
Executive Vice President and Head of Clinical Operations
2021
Elizabeth Hurlburt
CorMedix